Tuesday, November 22, 2016

BRIEF-Biolinerx reports Q3 financial results

* Bioline RX Ltd - operating loss for three months ended

September 30, 2016 amounted to $4.5 million versus operating

loss of $3.6 million

Read more

No comments:

Post a Comment